1(self.webpackChunk_N_E=self.webpackChunk_N_E||[]).push([[1287],{5498:(e,t,i)=>{"use strict";i.r(t),i.d(t,{default:()=>n});let n={src:"/_next/static/media/hero.489945f0.png",height:767,width:1440,blurDataURL:"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAgAAAAECAMAAACEE47CAAAAD1BMVEUODQwDAgIeHBo6NjMpJiSJ3ddrAAAACXBIWXMAAAsTAAALEwEAmpwYAAAAIUlEQVR4nCXGwQ0AMBDCsATYf+bqVL+MJGXlEvqj2wWFBwPaADGI3IA5AAAAAElFTkSuQmCC",blurWidth:8,blurHeight:4}},16546:(e,t,i)=>{"use strict";i.d(t,{default:()=>w});var n=i(95155),r=i(58402),a=i(73875),o=i(63354),s=i(51095),l=i(53267),d=i(63148),c=i(7068),h=i(65528),u=i(85222),g=i(68534),p=i(700),f=i(12115);let m={src:"/_next/static/media/laurel-wreaths-left.e462653a.svg",height:73,width:25,blurWidth:0,blurHeight:0},x={src:"/_next/static/media/laurel-wreaths-right.de05b8fb.svg",height:73,width:26,blurWidth:0,blurHeight:0};var b=i(66766);let y=e=>{let{award:t,radialBackground:i,mask:r}=e;return(0,n.jsxs)(c.default,{direction:{xs:"column",md:"row"},spacing:{xs:4,md:16},sx:{borderRadius:"16px",position:"relative",padding:"32px",background:i?"linear-gradient(89.43deg, rgba(48, 57, 88, 0.9) 12.72%, rgba(48, 57, 88, 0.05) 102.14%)":"transparent",color:"white"},children:[(0,n.jsxs)(c.default,{alignItems:"center",direction:"row",spacing:4,children:[r,(0,n.jsx)(b.default,{src:m,alt:"laurel-wreaths",width:25,height:73}),(0,n.jsxs)(c.default,{direction:"column",spacing:2,alignItems:"center",children:[(0,n.jsx)(p.default,{variant:"h3",sx:{fontWeight:{xs:700,md:800},fontSize:{xs:"24px",md:"28px"}},children:"Winner"}),(0,n.jsx)(p.default,{variant:"h3",sx:{fontWeight:{xs:700,md:400},fontSize:{xs:"24px",md:"28px"}},children:"".concat(t.year)})]}),(0,n.jsx)(b.default,{src:x,alt:"laurel-wreaths",width:25,height:73})]}),(0,n.jsx)(c.default,{direction:"column",spacing:1,sx:{width:"100%"},children:(0,n.jsx)(p.default,{variant:"body1",sx:{fontSize:{xs:"16px",md:"18px"}},children:"".concat(t.description)})})]})},v=e=>{let{awards:t,sx:i}=e,[r,o]=(0,f.useState)(!1),p=r?t:t.slice(0,3),m=t.length>3,x=()=>o(e=>!e),b=(0,s.A)(e=>e.breakpoints.down("sm")),v=(0,f.useMemo)(()=>r?t.length-1:2,[r,t]);return(0,n.jsxs)(l.default,{position:"relative",sx:{marginBottom:"150px",display:"flex",flexDirection:"column",alignItems:"center",gap:"20px",...i},children:[(0,n.jsx)(d.default,{children:p.map((e,t)=>(0,n.jsx)(c.default,{spacing:2,children:(0,n.jsx)(h.default,{children:(0,n.jsx)(u.default,{children:(0,n.jsx)(y,{award:e,radialBackground:0===t||b,mask:t===v&&m&&!r&&(0,n.jsx)(A,{expanded:r,toggle:x})})})})},t))}),r&&(0,n.jsxs)(g.default,{onClick:x,size:"small",variant:"text",color:"info",sx:{color:"info.dark",mx:"auto",bottom:"-20px"},children:["Load Less",(0,n.jsx)(a.A,{sx:{color:"info.dark"}})]})]})},A=e=>{let{expanded:t,toggle:i}=e;return(0,n.jsx)(l.default,{textAlign:"center",sx:{background:"linear-gradient(180deg, rgba(20, 27, 52, 0.5) 1%, rgba(20, 27, 52, 0.9) 50%, rgba(20, 27, 52, 1) 80%);",position:"absolute",inset:"-10px 0px -10px 0px",zIndex:3,display:"flex",alignItems:"center",justifyContent:"center"},children:(0,n.jsxs)(g.default,{onClick:i,size:"small",variant:"text",color:"info",sx:{color:"info.dark"},children:[t?"Load Less":"Load More",(0,n.jsx)(o.A,{sx:{color:"info.dark",transform:t?"rotate(180deg)":"rotate(0deg)"}})]})})},w=()=>{let[e,t]=(0,f.useState)(!1);return(0,n.jsxs)(c.default,{spacing:2,alignItems:"start",sx:{paddingInline:{xs:"16px",md:"150px"},paddingBlock:{xs:"64px",md:"50px"}},children:[(0,n.jsx)(p.default,{variant:"h2",color:"white",sx:{fontSize:{xs:"24px",md:"28px"}},children:"Research Prizes & Awards"}),(0,n.jsxs)(l.default,{sx:{width:"100%"},children:[(0,n.jsx)(g.default,{onClick:()=>{t(!e)},children:e?"Hide Details":"Show Details"}),(0,n.jsx)(v,{awards:r.V})]})]})}},52282:(e,t,i)=>{Promise.resolve().then(i.bind(i,53267)),Promise.resolve().then(i.bind(i,7068)),Promise.resolve().then(i.bind(i,700)),Promise.resolve().then(i.t.bind(i,33063,23)),Promise.resolve().then(i.bind(i,5498)),Promise.resolve().then(i.bind(i,54625)),Promise.resolve().then(i.bind(i,16546)),Promise.resolve().then(i.bind(i,66507))},54625:(e,t,i)=>{"use strict";i.r(t),i.d(t,{default:()=>n});let n={src:"/_next/static/media/team.bd8e955f.png",height:1641,width:4800,blurDataURL:"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAgAAAADCAMAAACZFr56AAAAMFBMVEV7YkqnlX65mX2si3WjiGbGrIV7bF+CZE5QPTSWc2mihmeVgWmCaF1iQjprUEBuRzxYQJfZAAAABnRSTlP+/v7+/vxR7dyOAAAA
1CXBIWXMAACxLAAAsSwGlPZapAAAAI0lEQVR4nGNgYWJmZGRkYmVg4OTn4+Vh52JgZ+Bh42DjZgAABssAlgRt5NoAAAAASUVORK5CYII=",blurWidth:8,blurHeight:3}},58402:(e,t,i)=>{"use strict";i.d(t,{V:()=>r,r:()=>n});let n=[{id:1,title:"Medical Education",description:"Prof. Mark Whiteley studied medicine at St. Bartholomewâs Hospital Medical School, qualifying in 1986 with an MB BS degree and a strong early interest in surgery.",start_date:"1981",end_date:"1986",thumbnail:"/_next/static/media/education.4bdbe42f.png"},{id:2,title:"Academic Surgery at Oxford",description:"Prof. Mark Whiteley was appointed Clinical Lecturer in Surgery at the University of Oxford, combining academic teaching with advanced surgical training through the NHS.",start_date:"1995",end_date:"1997",thumbnail:"/_next/static/media/surgery.9430dc25.png"},{id:3,title:"Leading Vascular Care in the NHS",description:"As Consultant Vascular Surgeon at the Royal Surrey County Hospital, Prof. Mark Whiteley led the vascular department, introducing new techniques and improving patient outcomes.",start_date:"1998",end_date:"2007",thumbnail:"/_next/static/media/nhs.74b8df43.png"},{id:4,title:"Founding The Whiteley Clinic",description:"In 1999, Prof. Mark Whiteley and the team founded The Whiteley Clinic to advance evidence-based, minimally invasive vein care. Today, with a strong research foundation and teaching programme, we are one of the UKâs fastest-growing medical clinicsârecognised nationally and internationally for clinical innovation.",start_date:"1999",end_date:"Present",thumbnail:"/_next/static/media/twc-expansion.d666f014.png"},{id:5,title:"Vein Treatment Innovation",description:"Prof. Mark Whiteley and the team performed the UKâs first endovenous thermal ablation in 1999. We later developed the TRLOP technique for perforator closure (2001), pioneered microwave ablation outside China (2019), and introduced the UKâs first commercial HIFU for varicose veins (2019).",start_date:"1999",end_date:"2019",thumbnail:"/_next/static/media/vein.84f60f46.png"},{id:6,title:"Expanding The Whiteley Clinic",description:"Starting from our base in Guildford, weâve expanded to London, Bristol, Poole, Liverpool and Manchester. We perform all treatments under local anaesthetic, using duplex scanning by specialist vascular scientists, with personalised care plans by our consultant surgeons.",start_date:"2003",end_date:"2025",thumbnail:"/_next/static/media/twc.fe353ce7.png"},{id:7,title:"Publishing & Education",description:"Prof. Mark Whiteley and the team performed the UKâs first endovenous thermal ablation in 1999. We later developed the TRLOP technique for perforator closure (2001), pioneered microwave ablation outside China (2019), and introduced the UKâs first commercial HIFU for varicose veins (2019).",start_date:"2007",end_date:"Present",thumbnail:"/_next/static/media/publishing.9c19b3cb.png"},{id:8,title:"Founding the College of Phlebology",description:"Prof. Mark Whiteley launched the College of Phlebology as a global online platform for doctors, sonographers, nurses and patients. It promotes education and research through the Venous Registry, online courses, and live surgery training programmes worldwide.",start_date:"2011",end_date:"Present",thumbnail:"/_next/static/media/phlebology.2b51ee8d.png"},{id:9,title:"Multiple National Prizes",description:"The Whiteley Clinic is globally recognised for excellence in venous care, especially pelvic vein reflux. Weâve won the GHP Best for Varicose Veins Award from 2020 to 2025 and featured in Tatlerâs Good Surgery Guide and other top media.",start_date:"2012",end_date:"2025",thumbnail:"/_next/static/media/awards.5f475ba9.png"},{id:10,title:"Academic Leadership",description:"In 2013, Prof. Mark Whiteley was appointed Visiting Professor at the University of Surrey. Prof. Mark Whiteley has supervised MD and PhD research into venous disorders, helping shape future specialists while supporting innovative clinical studies in phlebology.",start_date:"2013",end_date:"2021",thumbnail:"/_next/static/media/leadership.4d9f807f.png"},{id:11,title:"Pioneering HIFU at The Whiteley Clinic",description:"In 2019, The Whiteley Clinic became the worldâs first centre to offer HIFU commercially, providing a truly non-invasive, walk-in, walk-out treatment for varicose veins. The same year, it also became the UKâs first centre to offer Endovenous Micro Ablation.",start_date:"2019",end_date:"Present",thumbnail:"/_next/static/media/hifu.2bcb9338.png"},{id:12,title:"CMO Role for The Whiteley Clinic",description:"Since 2023, Prof. Mark Whiteley has served as Chief Medical Officer at Whiteley Medical Instruments, driving the development of cutting-edge technologies that underpin the latest walk-in, walk-out vein treatments delivered at The Whiteley Clinic.",start_date:"2023",end_date:"Present",thumbnail:"/_next/static/media/cmo.4de09e85.png"}],r=[{id:5,rank:1,year:2024,description:"GHP (Global Health & Pharma) Magazine â Global Excellence Awards 2024: Best for Varicose Veins Treatments 2024 â UK, The Whiteley Clinic (July 2024)"},{id:4,rank:1,year:2023,description:"GHP (Global Health & Pharma) Magazine â Global Excellence Awards 2023: Best for Varicose Veins Treatments 2023 â UK, The Whiteley Clinic (July 2023)"},{id:3,rank:1,year:2022,description:"GHP (Global Health & Pharma) Magazine â Global Excellence Awards 2022: Best for Varicose Veins Treatments 2022 â UK, The Whiteley Clinic (July 2022)"},{id:29,rank:1,year:2022,description:"British Society of Gynaecological Endoscopy ASM, Birmingham â April 2022: Silver Prize â Pelvic congestion syndrome retrospective cohort study"},{id:2,rank:1,year:2021,description:"GHP (Global Health & Pharma) Magazine â Global Excellence Awards 2021: Best for Varicose Veins Treatments 2021 â UK, The Whiteley Clinic (July 2021)"},{id:20,rank:1,year:2021,description:"American Vein and Lymphatic Society (AVLS) â October 2021: 1st Prize â Best Paper by a Trainee â Comparison of detergent and osmotic sclerosants"},{id:1,rank:1,year:2020,description:"GHP (Global Health & Pharma) Magazine â Global Excellence Awards 2020: Best for Varicose Veins Treatments 2020 â UK, The Whiteley Clinic (July 2020)"},{id:19,rank:1,year:2020,description:"MEDX Xelerator Vascular Challenge â December 2020: Novel catheter-based non-thermal endovenous ablation device for pelvic venous reflux"},{id:28,rank:1,year:2019,description:"Society of Vascular Technologists AGM at VSSGBI, Manchester â November 2019: First Prize â Role of ultrasound in HIFU treatment"},{id:18,rank:1,year:2019,description:"American Vein and Lymphatic Society (AVLS), Phoenix â November 2019: 2nd Prize â Best International Presentation â HIFU treatment of venous incompetence"},{id:17,rank:1,year:2019,description:"Pan Arab Interventional Radiology Society Conference, Dubai â March 2019: 2nd Prize â Best Presentation on left ovarian vein reflux"},{id:16,rank:1,year:2019,description:"American Venous Forum Annual Meeting, Palm Springs â February 2019: 1st Prize â Best Poster â Laser power output during EVLA"},{id:15,rank:1,year:2018,description:"Controversies & Updates in Vascular Surgery (CACVS), Paris â January 2018: Third Prize â Left Ovarian Vein Reflux as an ascending disease progression"},{id:14,rank:1,year:2017,description:"International Session vWin Foundation & American College of Phlebology, Austin â November 2017: 2nd Prize â Poster Presentation on interaction of endovenous ablation techniques"},{id:13,rank:1,year:2017,description:"31st Annual Conference of the American College of Phlebology, Austin â November 2017: Third Prize â Vulval Varicose Veins â Associations with Parity"},{id:12,rank:1,year:2017,description:"31st Annual Conference of the American College of Phlebology, Austin â November 2017: First Prize â Best Research Paper of Conference"},{id:11,rank:1,year:2017,description:"Society for Vascular Surgery Vascular Annual Meeting, San Diego â June 2017: Journal of Vascular Surgery â Venous and Lymphatic Disorders Most Highly Cited Article Award"},{id:10,rank:1,year:2016,description:"30th Annual Congress of the American College of Phlebology, Anaheim â November 2016: Bronze Medal â Differences in GSV ablation by endovenous lasers"},{id:9,rank:1,year:2015,description:"Charing Cross International Symposium, London â April 2015: Certificate of Merit â Intra-operative transvaginal duplex ultrasound"},{id:27,rank:1,year:2015,description:"Venous Forum Spring Meeting, RSM, London â May 2015: First Prize â Biological effects of the 1920nm laser on vein wall"},{id:8,rank:1,year:2014,description:"American College of Phlebology Congress, Phoenix â November 2014: Bronze Abstract Award â MOCA vs sclerotherapy study"},{id:26,rank:1,year:2014,description:"Venous Forum Spring Meeting, RSM, London â April 2014: First Prize â Foam sclerotherapy variable effects"},{id:25,rank:1,year:2013,description:"Venous Forum Spring Meeting, RSM, London â April 2013: Best Poster â Ten-year results of radiofrequency ablation"}
1,{id:7,rank:1,year:2010,description:"11th IVEC & 4th European Congress of ISVS, Milan â October 2010: 3rd Place â In vitro study on RFiTT"},{id:24,rank:1,year:2007,description:"Venous Forum RSM, Bristol â March 2007: Second Prize â Laser fibre damage during EVLA"},{id:23,rank:1,year:2006,description:"Society of Vascular Technologists AGM, Edinburgh â November 2006: Best Paper â Pelvic vein reflux prevalence"},{id:22,rank:1,year:2004,description:"Vascular Surgical Society of GB & Ireland, Harrogate â November 2004: Venous Forum Prize â Perforator veins trial"},{id:21,rank:1,year:2002,description:"National Society of Vascular Technologists AGM, Belfast â November 2002: Best Paper â VTE prevention in air travel"},{id:6,rank:1,year:2001,description:"European Venous Forum â Rome â September 2001: 3rd Prize â The saphenofemoral valve study"}]},66507:(e,t,i)=>{"use strict";i.d(t,{default:()=>w});var n=i(95155);let r={src:"/_next/static/media/chapter-bg.8549d9ed.png"};var a=i(58402),o=i(63114),s=i(71674),l=i(7068),d=i(53267),c=i(700),h=i(68534),u=i(12115),g=i(66766);let p=e=>{let{chapter:t}=e;return(0,n.jsxs)(l.default,{direction:"column",spacing:5,sx:{height:"100%",width:"100vw",alignItems:"center"},children:[(0,n.jsxs)(l.default,{spacing:2,direction:"column",paddingInline:"16px",sx:{userSelect:"none"},children:[(0,n.jsx)(c.default,{variant:"h4",color:"white",children:t.title}),(0,n.jsx)(c.default,{variant:"body2",sx:{fontWeight:400},color:"white",children:t.description}),(0,n.jsxs)(c.default,{variant:"subtitle1",color:"text.low",sx:{fontWeight:300},children:[t.start_date," - ",t.end_date]})]}),(0,n.jsx)(d.default,{sx:{width:"285px",height:"215px",position:"relative"},children:(0,n.jsx)(g.default,{src:t.thumbnail,alt:t.title,fill:!0,onContextMenu:e=>e.preventDefault()})})]})},f=e=>{let{chapter:t,sx:i}=e;return(0,n.jsxs)(d.default,{sx:{position:"relative",paddingInline:"100px",display:"grid",gridTemplateColumns:"1fr 1fr 4fr 0.75fr 1.25fr",alignItems:"center",gap:"30px",...i},children:[(0,n.jsx)(g.default,{src:t.thumbnail,alt:t.title,style:{transform:"rotate(-8.72deg)",objectFit:"cover",visibility:t.id%2?"visible":"hidden",gridColumnStart:1,gridColumnEnd:3},width:285,height:215}),(0,n.jsxs)(l.default,{spacing:2,sx:{paddingInline:"20px",gridColumnStart:3,gridColumnEnd:t.id%2?5:4},children:[(0,n.jsx)(c.default,{variant:"h1",color:"white",sx:{fontSize:"36px",fontWeight:600},children:t.title}),(0,n.jsx)(c.default,{variant:"body3",color:"white",children:t.description}),(0,n.jsxs)(c.default,{variant:"subtitle1",color:"text.low",sx:{fontWeight:300},children:[t.start_date," - ",t.end_date]})]}),(0,n.jsx)(g.default,{src:t.thumbnail,alt:t.title,style:{transform:"rotate(14.43deg)",objectFit:"cover",display:t.id%2?"none":"block",gridColumnStart:4,gridColumnEnd:6},width:285,height:215})]})};var m=i(46896),x=i(8296),b=i(19114);let y=(0,u.forwardRef)((e,t)=>{let{items:i,duration:r=1e4}=e,[a,o]=(0,u.useState)(0),[s,c]=(0,u.useState)(0),[h,g]=(0,u.useState)(!1),p=(0,m.s)();return(0,u.useImperativeHandle)(t,()=>({next:()=>{o(e=>e+1<i.length?e+1:0),c(e=>e+1)},prev:()=>{o(e=>e-1>=0?e-1:i.length-1),c(e=>e+1)}})),(0,u.useEffect)(()=>{if(h)return;let e=setTimeout(()=>{o(e=>e+1<i.length?e+1:0),c(e=>e+1)},r);return()=>clearTimeout(e)},[a,r,i.length,h]),(0,u.useEffect)(()=>{h?p.stop():p.start({width:"100%",transition:{duration:r/1e3,ease:"linear"}})},[h,s]),(0,n.jsxs)(l.default,{spacing:2,sx:{width:"100%",height:"100%"},onMouseDown:()=>g(!0),onMouseUp:()=>g(!1),onMouseLeave:()=>g(!1),onTouchStart:()=>g(!0),onTouchEnd:()=>g(!1),children:[(0,n.jsx)(l.default,{direction:"row",spacing:.5,sx:{px:2},children:i.map((e,t)=>(0,n.jsx)(d.default,{sx:{flex:1,height:3,bgcolor:"grey.400",borderRadius:2,overflow:"hidden",position:"relative"},children:t===a?(0,n.jsx)(x.P.div,{initial:{width:"0%"},animate:p,style:{height:"100%",backgroundColor:"white",position:"absolute",top:0,left:0}},s):(0,n.jsx)(d.default,{sx:{width:t<a?"100%":"0%",height:"100%",bgcolor:"white"}})},t))}),(0,n.jsx)(d.default,{sx:{flex:1,position:"relative"},children:(0,n.jsx)(b.N,{mode:"wait",children:(0,n.jsx)(x.P.div,{initial:{opacity:0}
1,animate:{opacity:1},exit:{opacity:0},transition:{duration:.5},style:{width:"100%",height:"100%",position:"absolute",top:0,left:0},children:i[a].content},i[a].id)})})]})});y.displayName="StoryViewer";let v=()=>(0,n.jsxs)(l.default,{spacing:6,direction:"column",alignItems:"center",sx:{paddingTop:"100px",paddingBottom:"100px",backgroundImage:" linear-gradient(rgb(0,0,0,0.4), rgb(0,0,0,0.4)),\nurl(".concat(r.src,")"),backgroundSize:"cover",backgroundPosition:"center",paddingInline:"120px",width:"100%",position:"relative",display:{xs:"none",md:"flex"}},children:[a.r.map(e=>(0,n.jsx)(f,{chapter:e,sx:{zIndex:1}},e.id)),(0,n.jsx)(d.default,{sx:{background:"linear-gradient(180deg, rgba(20, 27, 52, 0) 11.26%, #141B34 94.49%);",width:"100%",height:"100px",position:"absolute",bottom:0,zIndex:1}})]}),A=()=>{let e=(0,u.useRef)(null),t=(0,u.useRef)(null),i=(0,u.useRef)(null);return(0,n.jsxs)(l.default,{direction:"column",alignItems:"center",spacing:1,sx:{display:{xs:"flex",md:"none"},position:"relative",width:"100%",height:"637px",backgroundColor:"rgba(16, 14, 7, 1)",paddingBlock:"50px"},children:[(0,n.jsx)(c.default,{variant:"body2",color:"white",paddingInline:"30px",marginBlock:"16px",alignSelf:"start",children:"Career story..."}),(0,n.jsx)(y,{ref:i,items:a.r.map(e=>({id:e.id.toString(),content:(0,n.jsx)(p,{chapter:e})}))}),(0,n.jsxs)(l.default,{direction:"row",justifyContent:"center",alignItems:"center",children:[(0,n.jsx)(h.default,{variant:"text",ref:e,onClick:()=>{var e;return null==(e=i.current)?void 0:e.prev()},size:"large",sx:{color:"white",width:"fit-content"},endIcon:(0,n.jsx)(o.A,{sx:{fontSize:"28px"}})}),(0,n.jsx)(h.default,{variant:"text",ref:t,onClick:()=>{var e;return null==(e=i.current)?void 0:e.next()},size:"large",sx:{color:"white",width:"fit-content"},startIcon:(0,n.jsx)(s.A,{sx:{fontSize:"28px"}})})]}),(0,n.jsx)(d.default,{sx:{background:"linear-gradient(180deg, rgba(20, 27, 52, 0) 11.26%, #141B34 94.49%);",width:"100%",height:"37px",position:"absolute",bottom:"0px",zIndex:2}})]})},w=()=>(0,n.jsxs)(l.default,{sx:{width:"100%",height:"fit-content"},children:[(0,n.jsx)(v,{}),(0,n.jsx)(A,{})]})}},e=>{var t=t=>e(e.s=t);e.O(0,[3892,8645,9532,8534,3063,4395,7595,7944,8441,1684,7358],()=>t(52282)),_N_E=e.O()}]);
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.